Bussolati Benedetta, Bruno Stefania, Grange Cristina, Buttiglieri Stefano, Deregibus Maria Chiara, Cantino Dario, Camussi Giovanni
Cattedra di Nefrologia, Dipartimento di Medicina Interna, Ospedale Maggiore S. Giovanni Battista, Corso Dogliotti 14, 10126 Turin, Italy.
Am J Pathol. 2005 Feb;166(2):545-55. doi: 10.1016/S0002-9440(10)62276-6.
We describe here isolation and characterization of CD133+ cells derived from normal adult human kidney. These cells lacked the expression of hematopoietic markers and expressed PAX-2, an embryonic renal marker, suggesting their renal origin. Renal tissue-derived CD133+ cells and clones of individual cells were capable of expansion and limited self-renewal and differentiated in vitro into epithelial or endothelial cells. On subcutaneous implantation in SCID mice, the undifferentiated cells formed tubular structures expressing renal epithelial markers. At variance, when differentiated in endothelial cells, these cells formed functional vessels. On intravenous injection in SCID mice with glycerol-induced tubulonecrosis, the in vitro expanded renal-derived CD133+ cells homed into the injured kidney and integrated in tubules. We propose that CD133+ cells from kidney represent a multipotent adult resident stem cell population that may contribute to the repair of renal injury.
我们在此描述从正常成人肾脏中分离和鉴定CD133+细胞的过程。这些细胞缺乏造血标志物的表达,并表达胚胎肾标志物PAX-2,表明它们起源于肾脏。肾组织来源的CD133+细胞和单个细胞克隆能够扩增并进行有限的自我更新,并在体外分化为上皮细胞或内皮细胞。在SCID小鼠皮下植入时,未分化细胞形成表达肾上皮标志物的管状结构。不同的是,当这些细胞分化为内皮细胞时,它们形成了功能性血管。在甘油诱导肾小管坏死的SCID小鼠静脉注射时,体外扩增的肾源性CD133+细胞归巢到受损肾脏并整合到肾小管中。我们提出,肾脏来源的CD133+细胞代表了一种多能成年常驻干细胞群体,可能有助于肾损伤的修复。